123 related articles for article (PubMed ID: 31263525)
1. Analysis of Mortality Rate of Illicit Substance Abuse and its Trend in Five Years in Iran, 2014-2018.
Shahbazi F; Mirtorabi D; Ghadirzadeh MR; Hashemi-Nazari SS
Addict Health; 2018 Oct; 10(4):260-268. PubMed ID: 31263525
[TBL] [Abstract][Full Text] [Related]
2. Characterizing Mortality from Substance Abuse in Iran: An Epidemiological Study during March 2014 to February 2015.
Shahbazi F; Mirtorabi SD; Ghadirzadeh MR; Hashemi-Nazari SS; Barzegar A
Addict Health; 2017 Jul; 9(3):166-174. PubMed ID: 29657697
[TBL] [Abstract][Full Text] [Related]
3. Epidemiological Study of Mortality Rate from Alcohol and Illicit Drug Abuse in Iran.
Ghoreishi SMS; Shahbazi F; Mirtorabi SD; Ghadirzadeh MR; Hashemi Nazari SS
J Res Health Sci; 2017 Oct; 17(4):e00395. PubMed ID: 29233952
[TBL] [Abstract][Full Text] [Related]
4. Years of Life Lost (YLLs) due to drug-related deaths in the Islamic Republic Of Iran (2014-2017): a temporal and geographic pattern.
Alipour A; Babakhanian M; Zarghami M; Khosravi A; Saberi M
Cien Saude Colet; 2022 Jul; 27(7):2843-2854. PubMed ID: 35730851
[TBL] [Abstract][Full Text] [Related]
5. Bayesian spatial analysis of age differences and geographical variations in illicit-drug-related mortality in the Islamic Republic of Iran.
Rostami M; Jalilian A; Ghadirzadeh MR; Nazparvar B; Rezaei-Zangeneh R; Karamouzian M
East Mediterr Health J; 2023 Jan; 29(1):24-32. PubMed ID: 36710611
[TBL] [Abstract][Full Text] [Related]
6. Spatial distribution and temporal trend of drug-related deaths in the Islamic Republic of Iran during 2014-2017.
Alipour A; Zarghami M; Pordanjani SR; Khosravi A; Saberi M; Babakhanian M
East Mediterr Health J; 2022 Oct; 28(10):758-767. PubMed ID: 36382731
[TBL] [Abstract][Full Text] [Related]
7. Controlled Substance Prescribing Patterns--Prescription Behavior Surveillance System, Eight States, 2013.
Paulozzi LJ; Strickler GK; Kreiner PW; Koris CM;
MMWR Surveill Summ; 2015 Oct; 64(9):1-14. PubMed ID: 26469747
[TBL] [Abstract][Full Text] [Related]
8. [Not Available].
Pérez Benítez CI; Vicente B; Zlotnick C; Kohn R; Johnson J; Valdivia S; Rioseco P
Salud Ment (Mex); 2009 Jan; 32(2):145-153. PubMed ID: 21113425
[TBL] [Abstract][Full Text] [Related]
9. Risk factors for high levels of prescription drug misuse and illicit drug use among substance-using young men who have sex with men (YMSM).
Kecojevic A; Wong CF; Corliss HL; Lankenau SE
Drug Alcohol Depend; 2015 May; 150():156-63. PubMed ID: 25772436
[TBL] [Abstract][Full Text] [Related]
10. Surveillance for Violent Deaths - National Violent Death Reporting System, 32 States, 2016.
Ertl A; Sheats KJ; Petrosky E; Betz CJ; Yuan K; Fowler KA
MMWR Surveill Summ; 2019 Oct; 68(9):1-36. PubMed ID: 31581165
[TBL] [Abstract][Full Text] [Related]
11. CDC National Health Report: leading causes of morbidity and mortality and associated behavioral risk and protective factors--United States, 2005-2013.
Johnson NB; Hayes LD; Brown K; Hoo EC; Ethier KA;
MMWR Suppl; 2014 Oct; 63(4):3-27. PubMed ID: 25356673
[TBL] [Abstract][Full Text] [Related]
12. Patterns and 14-year trends in mortality among illicit drug users in Finland: the HUUTI study.
Onyeka IN; Beynon CM; Hannila ML; Tiihonen J; Föhr J; Tuomola P; Kuikanmäki O; Tasa N; Paasolainen M; Kauhanen J
Int J Drug Policy; 2014 Nov; 25(6):1047-53. PubMed ID: 25151335
[TBL] [Abstract][Full Text] [Related]
13. Prescription drugs, alcohol, and illicit substance use and their correlations among medical sciences students in iran.
Abbasi-Ghahramanloo A; Fotouhi A; Zeraati H; Rahimi-Movaghar A
Int J High Risk Behav Addict; 2015 Mar; 4(1):e21945. PubMed ID: 25821750
[TBL] [Abstract][Full Text] [Related]
14. Mortality and Cause of Death-A 30-Year Follow-Up of Substance Misusers in Sweden.
von Greiff N; Skogens L; Berlin M; Bergmark A
Subst Use Misuse; 2018 Oct; 53(12):2043-2051. PubMed ID: 29578830
[TBL] [Abstract][Full Text] [Related]
15. Surveillance for Violent Deaths - National Violent Death Reporting System, 27 States, 2015.
Jack SPD; Petrosky E; Lyons BH; Blair JM; Ertl AM; Sheats KJ; Betz CJ
MMWR Surveill Summ; 2018 Sep; 67(11):1-32. PubMed ID: 30260938
[TBL] [Abstract][Full Text] [Related]
16. Prediction of psychiatric comorbidity on premature death in a cohort of patients with substance use disorders: a 42-year follow-up.
Fridell M; Bäckström M; Hesse M; Krantz P; Perrin S; Nyhlén A
BMC Psychiatry; 2019 May; 19(1):150. PubMed ID: 31092225
[TBL] [Abstract][Full Text] [Related]
17. Trends in Poly Drug Use-associated Deaths based on Confirmed Analytical Toxicology Results in Tehran, Iran, in 2011-2016.
Akhgari M; Sardari-Iravani F; Ghadipasha M
Addict Health; 2021 Jan; 13(1):18-28. PubMed ID: 33995956
[TBL] [Abstract][Full Text] [Related]
18. Trends in Mortality From Novel Psychoactive Substances as "Legal Highs": Gender Differences in Manner of Death and Implications for Risk Differences for Women.
Webb L; Shi X; Goodair C; Cheeta S
Front Psychiatry; 2022; 13():890840. PubMed ID: 35530022
[TBL] [Abstract][Full Text] [Related]
19. Online Conversation Monitoring to Understand the Opioid Epidemic: Epidemiological Surveillance Study.
Black JC; Margolin ZR; Olson RA; Dart RC
JMIR Public Health Surveill; 2020 Jun; 6(2):e17073. PubMed ID: 32597786
[TBL] [Abstract][Full Text] [Related]
20. Time Series Modeling and Forecasting of Drug-Related Deaths in Iran (2014-2016).
Zarghami M; Kharazmi O; Alipour A; Babakhanian M; Khosravi A; Mirtorabi SD
Addict Health; 2023 Jul; 15(3):149-155. PubMed ID: 38026723
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
